Long Term Outcomes of Open Versus Endovascular AAA Repair
Long Term Outcomes of Open Versus Endovascular AAA Repair
批准号:
8020566
负责人:
Bruce E. Landon
金额:
$73.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-15 至 2014-06-30
关键词:
Abdominal Aortic AneurysmAgeBlood VesselsCause of DeathCessation of lifeClinical TrialsCollaborationsDataDevicesElderlyElderly manEmployee StrikesGeneral PopulationGrantHeadHealth Services ResearchHerniaHome Nursing CareInterventionIntervention StudiesIntestinal ObstructionLaparotomyLiving CostsLongitudinal StudiesMeasuresMedicareMorbidity - disease rateOperative Surgical ProceduresOutcomePatientsPerioperativePopulationPositioning AttributeQuality of lifeRandomized Controlled TrialsRehabilitation NursingReportingResearchRuptureRuptured Abdominal Aortic AneurysmSamplingScoring MethodStatistical MethodsTechniquesTechnologyTimeUnited StatesUnited States Centers for Medicare and Medicaid ServicesWorkbasecohortcomparative effectivenessfollow-uphead-to-head comparisonmembermenmortalityolder patientpreventprogramsrandomized trialrepaired
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ruptured abdominal aortic aneurysm (AAA) is the 10th leading cause of death in men over age 55 in the US with mortality of ruptured AAA exceeding 80%. Up until recently, to prevent ruptures, elective Open AAA repair was typically performed with mortality of d5%. Within the last decade, endovascular AAA repair was introduced as a less invasive alternative to open repair. FDA approval for stentgraft repair of AAA in the United States was granted in 1999 and the use of endovascular repair has steadily grown since that time, replacing open surgery for many patients. Over 40,000 AAA repairs are performed annually in the United States and by 2005, 56% of all elective AAA repairs performed in the Medicare population were endovascular. Endovascular AAA repair has been shown to have a lower operative mortality and morbidity than open repair in short-term head to head comparisons. However, recent randomized trials have not demonstrated a sustained mortality benefit with endovascular repair. Endovascular repair also requires costly follow-up surveillance and there is a greater need for re-interventions, although endovascular technologies continue to evolve. In order to understand the comparative effectiveness of various interventions, it is important to extend inquiry beyond small randomized controlled trials of ideal populations to study interventions in real world settings using observational data. In the case of AAA repair, access to comprehensive data from the Medicare program represents an ideal setting in which to perform comparative effectiveness studies as the vast majority of AAA repairs (70%) are performed in this elderly population. Medicare data are also ideally suited to studies that include longer term follow-up and the occurrence of uncommon complications. The specific aims of this proposal are: 1) To study the long term outcomes of endovascular versus open AAA repair in a comprehensive sample of Medicare patients undergoing elective repair; 2) To determine whether changes in technology, as measured by the introduction of new endovascular products over time, has impacted both perioperative and long term survival of those undergoing endovascular repair; and 3) To rigorously define, quantify, and measure the impact of laparotomy related complications in the case of open AAA repair and graft-related complications in the case of endovascular repair.
PUBLIC HEALTH RELEVANCE: Ruptured aortic abdominal aneurysm (AAA) is the tenth leading cause of mortality in elderly men and over 40,000 elective repairs are performed annually in order to prevent these deaths. In 1999, a less invasive endovascular technique was introduced as an alternative to open surgical repair. In this study, we will evaluate the long term comparative effectiveness of open versus endovascular AAA repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Risk Aversion, Fear of Malpractice, and Medical Decision Making in the Emergency Department
-
批准号:10474364
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2019
-
负责人:Bruce E. Landon
-
依托单位:
Comparing Targeted and Non-Targeted Approaches to Improving the Value of Cancer Care Services
-
批准号:9895590
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2019
-
负责人:Bruce E. Landon
-
依托单位:
Risk Aversion, Fear of Malpractice, and Medical Decision Making in the Emergency Department
-
批准号:10242666
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2019
-
负责人:Bruce E. Landon
-
依托单位:
Comparing Targeted and Non-Targeted Approaches to Improving the Value of Cancer Care Services
-
批准号:10374837
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:Bruce E. Landon
-
依托单位:
PA-20-070 Identifying Predictors of Hospital Admission from the ED Among the Elderly
-
批准号:10175813
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2017
-
负责人:Bruce E. Landon
-
依托单位:
Identifying Predictors of Hospital Admission from the ED Among the Elderly
-
批准号:9365351
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2017
-
负责人:Bruce E. Landon
-
依托单位:
Identifying Predictors of Hospital Admission from the ED Among the Elderly
-
批准号:10015296
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2017
-
负责人:Bruce E. Landon
-
依托单位:
Long Term Outcomes of Open Versus Endovascular AAA Repair
-
批准号:8205001
-
项目类别:
-
资助金额:$62.27万
-
财政年份:2010
-
负责人:Bruce E. Landon
-
依托单位:
Long Term Outcomes of Open Versus Endovascular AAA Repair
-
批准号:8536355
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2010
-
负责人:Bruce E. Landon
-
依托单位:
Improving Medicare in an Era of Change: Deaths in Long-Term Care Facilities During the COVID-19 Era
-
批准号:10288393
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Looking Under the Hood of MA
-
批准号:10379883
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Administrative Core
-
批准号:10379880
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Improving Medicare in an Era of Change: Impact of Private Equity Acquisitions of Hospitals and Physicians on the Care of Medicare Beneficiaries with ADRD
-
批准号:10714444
-
项目类别:
-
资助金额:$42.29万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Administrative Core
-
批准号:10616693
-
项目类别:
-
资助金额:$13.33万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Administrative Core
-
批准号:10196899
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Improving Medicare in an Era of Change: Post-Acute Use and Outcomes During the Pandemic for Patients with Dementia
-
批准号:10288010
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Medicare in a Restructured Delivery System
-
批准号:9756126
-
项目类别:
-
资助金额:$176.84万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Administrative Core
-
批准号:10379887
-
项目类别:
-
资助金额:$43.67万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
Improving Medicare in an Era of Change
-
批准号:10196897
-
项目类别:
-
资助金额:$181.22万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
A Research Agenda for the Patient Centered Medical Home
-
批准号:7645339
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2009
-
负责人:Bruce E. Landon
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: